Author

E. V. Zuev

Observed names: E.V. Zuev, Evgene V. Zuev, Evgenii V. Zuev, Evgeniy V. Zuev, Зуев Е. В., Зуев Евгений Васильевич

Institution: Generium Pharmaceuticals (Russia)

Observed institutions: National Medical and Surgical Center named after N.I. Pirogov, V.A. Negovsky Scientific Research Institute of General Reanimatology, Generium Pharmaceuticals (Russia)

ORCID: 0000-0001-5519-8358

Observed ORCID: 0000-0001-5519-8358

OpenAlex ID: A5088568202

Causal Therapy of COVID-19: Critical Review and Prospects

2020 · N. V. Beloborodova, E. V. Zuev, et al. · General Reanimatology · 10

Comparative study of the clinical efficacy of the first domestic bioanalogue of tocilizumab based on the results of a randomized clinical trial of phase III

2024 · E. V. Akatova, Yu. S. Bakhareva, et al. · Modern Rheumatology Journal · 3

Virus neutralizing antibodies in pseudovirus particle neutralization reaction as a bioanalytical part of a Salnavac® vaccine clinical trial

2023 · Evgeniy V. Zuev, Oksana Anatolievna Markova, et al. · Russian Journal of Infection and Immunity · 3

T-cell sensitization dynamics after intranasal and intramuscular immunization with a two-component vector vaccine for the prevention of coronavirus infection based on Ad26 and Ad5

2024 · E.V. Zuev, O.A. Markova, et al. · Immunologiya · 2

Comparative safety evaluation of intranasal and intramuscular immunisation with Ad26 and Ad5-vectored vaccines to prevent coronavirus infection

2023 · E. V. Zuev, O. L. Evdokimova, et al. · Biological Products Prevention Diagnosis Treatment · 2

Results of a prospective observational study of imiglucerase biosimilar in adults with type I Gaucher disease

2025 · Elena A. Lukina, Rodion V. Ponomarev, et al. · Terapevticheskii arkhiv · 1

Evaluation of virus-neutralizing antibody level after novel coronavirus infection COVID-19: development of an instant assay assessing protective antibodies using a pseudovirus-based reaction

2023 · Andrey A. Funtikov, N. A. Litvinova, et al. · Russian Journal of Infection and Immunity

Результаты проспективного наблюдательного исследования биоаналога имиглюцеразы у взрослых пациентов с болезнью Гоше I типа

· Пономарев Родион Викторович, Лукина Елена Александровна, et al. · CyberLeninK (CyberLeninka)

Реакция Нейтрализации Псевдовирусных Частиц Вируснейтрализующими Антителами Как Биоаналитическая Часть Клинического Исследования Вакцины Салнавак

· Зуев Евгений Васильевич, О. А. Маркова, et al. · CyberLeninK (CyberLeninka)

Сравнительное изучение клинической эффективности первого отечественного биоаналога тоцилизумаба по результатам рандомизированного клинического исследования III фазы

· Акатова Е. В., Бахарева Ю. С., et al. · CyberLeninK (CyberLeninka)

Works count: 10

Citation count: 21

H-index: 3

I10-index: 1